Paper39273293
Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs.
Blaess M and 3 others. Int J Mol Sci, 2024. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs. Papers, record 39273293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39273293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dermatitis, Atopic | Major topic |
| Ceramides | Major topic |
| Fatty Acids | Major topic |
| Humans | |
| Fatty Acid Elongases | |
| Skin | |
| Animals |
Source PubMed
References126
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21835161 | Effect of ceramide structure on membrane biophysical properties: the role of acyl chain length and unsaturation. | Biochim Biophys Acta | 2011 | https://conductscience.org/library/papers/21835161 | PubMed |
| 2 | 10700391 | The existence of a lysosomal redox chain and the role of ubiquinone. | Arch Biochem Biophys | 2000 | https://conductscience.org/library/papers/10700391 | PubMed |
| 3 | 36473907 | Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry. | Sci Rep | 2022 | https://conductscience.org/library/papers/36473907 | PubMed |
| 4 | 34717820 | Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. | Lancet Glob Health | 2022 | https://conductscience.org/library/papers/34717820 | PubMed |
| 5 | 29467325 | Lipid abnormalities in atopic skin are driven by type 2 cytokines. | JCI Insight | 2018 | https://conductscience.org/library/papers/29467325 | PubMed |
| 6 | 3013856 | Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. | J Biol Chem | 1986 | https://conductscience.org/library/papers/3013856 | PubMed |
| 7 | 31484598 | Topical use of amitriptyline and linoleic acid to restore ceramide rheostat in atopic dermatitis lesions - a case report. | Pharmazie | 2019 | https://conductscience.org/library/papers/31484598 | PubMed |
| 8 | 21692241 | Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. | Biochim Biophys Acta | 2011 | https://conductscience.org/library/papers/21692241 | PubMed |
| 9 | 27803785 | Fluvoxamine inhibits some inflammatory genes expression in LPS/stimulated human endothelial cells, U937 macrophages, and carrageenan-induced paw edema in rat. | Iran J Basic Med Sci | 2016 | https://conductscience.org/library/papers/27803785 | PubMed |
| 10 | 20574438 | Changes in the ceramide profile of atopic dermatitis patients. | J Invest Dermatol | 2010 | https://conductscience.org/library/papers/20574438 | PubMed |
| 11 | 23826266 | Cooperative Synthesis of Ultra Long-Chain Fatty Acid and Ceramide during Keratinocyte Differentiation. | PLoS One | 2013 | https://conductscience.org/library/papers/23826266 | PubMed |
| 12 | 34743684 | Drug triggered pruritus, rash, papules, and blisters - is AGEP a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin? | Lipids Health Dis | 2021 | https://conductscience.org/library/papers/34743684 | PubMed |
| 13 | 18329855 | Omega-O-acylceramide, a lipid essential for mammalian survival. | J Dermatol Sci | 2008 | https://conductscience.org/library/papers/18329855 | PubMed |
| 14 | 18723117 | Mass spectrometric analysis of lipid species of human circulating blood cells. | Biochim Biophys Acta | 2008 | https://conductscience.org/library/papers/18723117 | PubMed |
| 15 | 20392164 | The lysosome among targets of metformin: new anti-inflammatory uses for an old drug? | Expert Opin Ther Targets | 2010 | https://conductscience.org/library/papers/20392164 | PubMed |
| 16 | 36439170 | Hypersensitivity reactions to small molecule drugs. | Front Immunol | 2022 | https://conductscience.org/library/papers/36439170 | PubMed |
| 17 | 30866656 | Lysosomal Acid Lipase in Lipid Metabolism and Beyond. | Arterioscler Thromb Vasc Biol | 2019 | https://conductscience.org/library/papers/30866656 | PubMed |
| 18 | 24252189 | The important role of stratum corneum lipids for the cutaneous barrier function. | Biochim Biophys Acta | 2014 | https://conductscience.org/library/papers/24252189 | PubMed |
| 19 | 12764132 | The reverse activity of human acid ceramidase. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12764132 | PubMed |
| 20 | 21184822 | A high content screening assay for identifying lysosomotropic compounds. | Toxicol In Vitro | 2011 | https://conductscience.org/library/papers/21184822 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42867756 | Delayed Drug Hypersensitivity: Mechanistic Advances and Emerging Therapies. | Curr Allergy Asthma Rep | 2026 | https://conductscience.org/library/papers/42867756 | PubMed |
| 42792748 | Portulaca oleracea L. Repairs the Skin Barrier and Alleviates Atopic Dermatitis by Targeting Lipid Metabolism to Regulate the JAK1/STAT3 Signaling Pathway and Downregulate Th2 Inflammatory Cytokines. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792748 | PubMed |
| 42547464 | Skin Lipid Dysregulation in Atopic Dermatitis and Related Inflammatory Skin Diseases. | Allergy Asthma Immunol Res | 2026 | https://conductscience.org/library/papers/42547464 | PubMed |
| 42346157 | IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction. | Cells | 2026 | https://conductscience.org/library/papers/42346157 | PubMed |
| 42327796 | Non-invasive detection of pediatric atopic dermatitis based on fecal microbiota and metabolite profiles: a diagnostic approach. | Front Immunol | 2026 | https://conductscience.org/library/papers/42327796 | PubMed |
| 42252268 | Skin Tape Stripping: A Non-Invasive Approach Linking Epidermal Changes and Systemic Inflammation in Atopic Dermatitis. | Clin Transl Allergy | 2026 | https://conductscience.org/library/papers/42252268 | PubMed |
| 42123967 | The Therapeutic Potential of Polyphenols in Modulating Barrier Lipids, Microbiome Interactions, and Inflammatory Pathways in Atopic Dermatitis. | Nutrients | 2026 | https://conductscience.org/library/papers/42123967 | PubMed |
| 41622295 | Palmitic acid aggravates atopic dermatitis by regulating SGK1/NEDD4L-involved cutaneous neuroimmune inflammation through driving TRPV1 and MRGPRB2 S-palmitoylation. | Inflamm Res | 2026 | https://conductscience.org/library/papers/41622295 | PubMed |
| 40366491 | Atopic Dermatitis: The Relationship Between Immune Mediators and Skin Lipid Barrier. | Clin Rev Allergy Immunol | 2025 | https://conductscience.org/library/papers/40366491 | PubMed |
| 40204503 | Skin Microbiome Dynamics in Atopic Dermatitis: Understanding Host-Microbiome Interactions. | Allergy Asthma Immunol Res | 2025 | https://conductscience.org/library/papers/40204503 | PubMed |
| 39769500 | Metabolic Biomarkers of Liver Failure in Cell Models and Patient Sera: Toward Liver Damage Evaluation In Vitro. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769500 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ELOVL6 | 79071 | PubTator's text mining | https://conductscience.org/library/genes/79071 | NCBI Gene |
| PPARG | 5468 | PubTator's text mining | https://conductscience.org/library/genes/5468 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39273293
GET https://conductscience.org/api/papers/v1/39273293/references?page=2